Your browser doesn't support javascript.
loading
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini, Chiara; Loupakis, Fotios; Antoniotti, Carlotta; Lupi, Cristiana; Sensi, Elisa; Lonardi, Sara; Mezi, Silvia; Tomasello, Gianluca; Ronzoni, Monica; Zaniboni, Alberto; Tonini, Giuseppe; Carlomagno, Chiara; Allegrini, Giacomo; Chiara, Silvana; D'Amico, Mauro; Granetto, Cristina; Cazzaniga, Marina; Boni, Luca; Fontanini, Gabriella; Falcone, Alfredo.
Afiliación
  • Cremolini C; Department of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Loupakis F; Department of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Antoniotti C; Department of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Lupi C; Department of Surgical Pathology, Medical, Molecular, and Critical Area, University of Pisa, Pisa, Italy.
  • Sensi E; Department of Surgical Pathology, Medical, Molecular, and Critical Area, University of Pisa, Pisa, Italy.
  • Lonardi S; Medical Oncology 1, Oncology Institute IRCCS Veneto, Padua, Italy.
  • Mezi S; Day Hospital of Oncology, Policlinico Umberto I, Rome, Italy.
  • Tomasello G; Division of Medicine and Medical Oncology, Hospital of Cremona, Cremona, Italy.
  • Ronzoni M; Department of Oncology, Hospital San Raffaele IRCSS, Milan, Italy.
  • Zaniboni A; Department of Medical Oncology, Poliambulanza Foundation, Brescia, Italy.
  • Tonini G; Medical Oncology, University Biomedical Campus, Rome, Italy.
  • Carlomagno C; Department of Clinical Medicine and Surgery, University Hospital Federico II, Naples, Italy.
  • Allegrini G; Unit of Medical Oncology, Hospital Felice Lotti, Pontedera, Italy.
  • Chiara S; Medical Oncology 2, IRCCS University Hospital San Martino, Genoa, Italy.
  • D'Amico M; Unit of Medical Oncology, Galliera Hospital, Genoa, Italy.
  • Granetto C; Unit of Medical Oncology, Medical Centre Hospital Santa Croce and Carle, Cuneo, Italy.
  • Cazzaniga M; Unit of Medical Oncology, Hospital San Gerardo, Monza, Italy.
  • Boni L; Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Florence, Italy.
  • Fontanini G; Department of Surgical Pathology, Medical, Molecular, and Critical Area, University of Pisa, Pisa, Italy.
  • Falcone A; Department of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. Electronic address: alfredo.falcone@med.unipi.it.
Lancet Oncol ; 16(13): 1306-15, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26338525
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Angiogénesis / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Angiogénesis / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido